Polysulfated glycosides and salts thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8987216
APP PUB NO 20110118198A1
SERIAL NO

13013153

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to polysulfated glycosides of formula (I), the pharmaceutically acceptable salts thereof, as well as the pharmaceutical compositions containing these compounds as active ingredients. Furthermore the invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic inflammatory disorders of the airways of mammals—including asthma and asthma-related pathologies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEVA HUNGARY PHARMACEUTICAL MARKETING PRIVATE LIMITED COMPANY / TEVA HUNGARY LTDREPULOTERI UT 5 GODOLLO 2100

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bodor, Nicholas Bal Harbour, US 12 141
Kurucz, István Budapest, HU 2 0
Kuszmann, János Budapest, HU 2 0
Medgyes, Gábor Budapest, HU 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 24, 2022
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 24, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00